Myovant Sciences Ltd. — Net Income by Fiscal Year
6 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/70d5cc3c-c0f9-4e7b-822f-4a47270fafe2/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2021 | $-206.0M | 2021-04-01 – 2022-03-31 | evidence 0001679082-22-000071 |
| FY 2020 | $-255.1M | 2020-04-01 – 2021-03-31 | evidence 0001679082-21-000017 |
| FY 2019 | $-289.0M | 2019-04-01 – 2020-03-31 | evidence 0001679082-20-000026 |
| FY 2018 | $-273.6M | 2018-04-01 – 2019-03-31 | evidence 0001679082-19-000019 |
| FY 2017 | $-143.3M | 2017-04-01 – 2018-03-31 | evidence 0001679082-18-000016 |
| FY 2016 | $-83.4M | 2016-04-01 – 2017-03-31 | evidence 0001679082-17-000009 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Myovant Sciences Ltd. — all facts · Revenue · Operating Income